WallStreetZen

NYSE: ABT
Abbott Laboratories Earnings & Revenue

ABT past earnings growth

How has ABT's earnings growth performed historically?
Company
2.15%
Industry
41.69%
Market
37.63%
ABT's earnings have grown slower (-8.91% per year) than the US Medical Devices industry average (20.06%)
Performance
ABT's earnings have grown slower (-8.91% per year) than the US market average (27.63%)
Performance
ABT's earnings growth is accelerating - its growth over the last year (2.15%) is above its 5-year compound annual rate (-8.91%)
Performance

ABT past revenue growth

How has ABT's revenue growth performed historically?
Company
2.76%
Industry
4.76%
Market
15.17%
ABT's revenue has grown slower (9.39% per year) than the US Medical Devices industry average (15.08%)
Performance
ABT's revenue has grown slower (9.39% per year) than the US market average (15.5%)
Performance
ABT's revenue growth is slowing down - its growth over the last year (2.76%) is below its 5-year compound annual rate (9.39%)
Performance

ABT earnings and revenue history

Current Revenue
$32.2B
Current Earnings
$3.4B
Current Profit Margin
10.5%
ABT's has not demonstrated consistent long-term earnings growth over the past 10 years (-37.91%)
Performance

ABT Return on equity

Current Company
10.9%
Current Industry
11.3%
Current Market
23.9%
ABT's Return on Equity (10.9%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

ABT Return on assets

Current Company
5%
Current Industry
6.2%
Current Market
6.2%
ABT is generating lower Return on Assets (5%) than the US Medical Devices industry average (6.68%)
Performance

ABT Return on capital employed

Current Company
7.51%
Current Industry
5.8%
ABT has gotten more efficient at generating Return on Capital (7.51%) compared to 3 years ago (5.39%)
Performance

ABT earnings dates

Next earnings date
Jan 27, 2021

Abbott Laboratories Earnings & Revenue FAQ

What were ABT's earnings last quarter?

On Oct 21, 2020, Abbott Laboratories (NYSE: ABT) reported Q3 2020 earnings per share (EPS) of $0.69, up 27.78% year over year. Total Abbott Laboratories earnings for the quarter were $1.23 billion. In the same quarter last year, Abbott Laboratories's earnings per share (EPS) was $0.54.

What was ABT's revenue last quarter?

On Oct 21, 2020, Abbott Laboratories (NYSE: ABT) reported Q3 2020 revenue of $8.85 billion up 9.62% year over year. In the same quarter last year, Abbott Laboratories's revenue was $8.08 billion.

What was ABT's earnings growth in the past year?

As of Q1 2021, Abbott Laboratories's earnings has grown 2.15% year over year. This is 39.54 percentage points lower than the US Medical Devices industry earnings growth rate of 41.69%. Abbott Laboratories's earnings in the past year totalled $3.38 billion.

What was ABT's revenue growth in the past year?

As of Q1 2021, Abbott Laboratories's revenue has grown 2.76% year over year. This is 1.99 percentage points lower than the US Medical Devices industry revenue growth rate of 4.76%. Abbott Laboratories's revenue in the past year totalled $32.22 billion.

What is ABT's earnings date?

Abbott Laboratories's earnings date is Jan 27, 2021. Add ABT to your watchlist to be reminded of ABT's next earnings announcement.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics